Determinants of Response and Molecular Dynamics in HER2+ER+ Breast Cancers from the NA-PHER2 Trial Receiving HER2-targeted and Endocrine Therapies
Nature communications(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined